GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » COSMOS Pharmaceutical Corp (OTCPK:CSMYF) » Definitions » Equity-to-Asset

COSMOS Pharmaceutical (COSMOS Pharmaceutical) Equity-to-Asset : 0.52 (As of Feb. 2024)


View and export this data going back to 2014. Start your Free Trial

What is COSMOS Pharmaceutical Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. COSMOS Pharmaceutical's Total Stockholders Equity for the quarter that ended in Feb. 2024 was $1,499 Mil. COSMOS Pharmaceutical's Total Assets for the quarter that ended in Feb. 2024 was $2,876 Mil. Therefore, COSMOS Pharmaceutical's Equity to Asset Ratio for the quarter that ended in Feb. 2024 was 0.52.

The historical rank and industry rank for COSMOS Pharmaceutical's Equity-to-Asset or its related term are showing as below:

CSMYF' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.37   Med: 0.46   Max: 0.54
Current: 0.52

During the past 13 years, the highest Equity to Asset Ratio of COSMOS Pharmaceutical was 0.54. The lowest was 0.37. And the median was 0.46.

CSMYF's Equity-to-Asset is ranked better than
56.74% of 675 companies
in the Healthcare Providers & Services industry
Industry Median: 0.47 vs CSMYF: 0.52

COSMOS Pharmaceutical Equity-to-Asset Historical Data

The historical data trend for COSMOS Pharmaceutical's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

COSMOS Pharmaceutical Equity-to-Asset Chart

COSMOS Pharmaceutical Annual Data
Trend May14 May15 May16 May17 May18 May19 May20 May21 May22 May23
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.46 0.46 0.50 0.53 0.50

COSMOS Pharmaceutical Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.54 0.50 0.50 0.51 0.52

Competitive Comparison of COSMOS Pharmaceutical's Equity-to-Asset

For the Pharmaceutical Retailers subindustry, COSMOS Pharmaceutical's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


COSMOS Pharmaceutical's Equity-to-Asset Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, COSMOS Pharmaceutical's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where COSMOS Pharmaceutical's Equity-to-Asset falls into.



COSMOS Pharmaceutical Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

COSMOS Pharmaceutical's Equity to Asset Ratio for the fiscal year that ended in May. 2023 is calculated as

Equity to Asset (A: May. 2023 )=Total Stockholders Equity/Total Assets
=1540.066/3071.559
=0.50

COSMOS Pharmaceutical's Equity to Asset Ratio for the quarter that ended in Feb. 2024 is calculated as

Equity to Asset (Q: Feb. 2024 )=Total Stockholders Equity/Total Assets
=1499.048/2875.654
=0.52

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


COSMOS Pharmaceutical  (OTCPK:CSMYF) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


COSMOS Pharmaceutical Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of COSMOS Pharmaceutical's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


COSMOS Pharmaceutical (COSMOS Pharmaceutical) Business Description

Traded in Other Exchanges
Address
4 floor,10th first Fukuoka S Building Museum, Hakataekihigashi 2-chome,, Fukuoka, JPN, 812-0013
COSMOS Pharmaceutical Corp manages retail drugstores in Japan. The company places a strong emphasis on convenience regarding its product selection, which includes medical products, health and beauty aids, personal-care items, discount cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, alcoholic beverages, tobacco, insect repellent, and miscellaneous everyday consumables. The majority of the company's revenue is derived from common grocery sales. Cosmos also operates a private grocery brand called ON 365.

COSMOS Pharmaceutical (COSMOS Pharmaceutical) Headlines

From GuruFocus

Matthews Japan Fund Reduces Stake in COSMOS

By Kyle Ferguson Kyle Ferguson 08-12-2016

Hennessy Japan Small Cap Fund Adds 5 Stocks to Portfolio

By Sydnee Gatewood Sydnee Gatewood 01-10-2020